Annual Cash & Cash Equivalents
$9.69 M
+$2.59 M+36.41%
December 1, 2023
Summary
- As of February 22, 2025, NNNN annual cash & cash equivalents is $9.69 million, with the most recent change of +$2.59 million (+36.41%) on December 1, 2023.
- During the last 3 years, NNNN annual cash & cash equivalents has risen by +$5.51 million (+131.70%).
Performance
NNNN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$10.31 M
+$622.40 K+6.42%
June 1, 2024
Summary
- As of February 22, 2025, NNNN quarterly cash and cash equivalents is $10.31 million, with the most recent change of +$622.40 thousand (+6.42%) on June 1, 2024.
- Over the past year, NNNN quarterly cash and cash equivalents has dropped by -$250.80 thousand (-2.37%).
Performance
NNNN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NNNN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.4% | -2.4% |
| 3 y3 years | +131.7% | -2.4% |
| 5 y5 years | +131.7% | -2.4% |
NNNN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -56.8% | -2.4% | -31.1% |
| 5 y | 5-year | at high | -56.8% | -2.4% | -31.1% |
| alltime | all time | at high | -56.8% | -2.4% | -31.1% |
Anbio Biotechnology Class A Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $10.31 M(+6.4%) |
| Dec 2023 | $9.69 M | $9.69 M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $10.56 M(+48.7%) |
| Dec 2022 | $7.10 M(+69.9%) | $7.10 M |
| Dec 2021 | $4.18 M | - |
FAQ
- What is Anbio Biotechnology Class A annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Anbio Biotechnology Class A?
- What is Anbio Biotechnology Class A annual cash & cash equivalents year-on-year change?
- What is Anbio Biotechnology Class A quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Anbio Biotechnology Class A?
- What is Anbio Biotechnology Class A quarterly cash and cash equivalents year-on-year change?
What is Anbio Biotechnology Class A annual cash & cash equivalents?
The current annual cash & cash equivalents of NNNN is $9.69 M
What is the all time high annual cash & cash equivalents for Anbio Biotechnology Class A?
Anbio Biotechnology Class A all-time high annual cash & cash equivalents is $9.69 M
What is Anbio Biotechnology Class A annual cash & cash equivalents year-on-year change?
Over the past year, NNNN annual cash & cash equivalents has changed by +$2.59 M (+36.41%)
What is Anbio Biotechnology Class A quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NNNN is $10.31 M
What is the all time high quarterly cash and cash equivalents for Anbio Biotechnology Class A?
Anbio Biotechnology Class A all-time high quarterly cash and cash equivalents is $10.56 M
What is Anbio Biotechnology Class A quarterly cash and cash equivalents year-on-year change?
Over the past year, NNNN quarterly cash and cash equivalents has changed by -$250.80 K (-2.37%)